Tumor Necrosis Factor in Middle Ear Effusions

Archives of Otolaryngology--Head and Neck Surgery

Volumn 114, Issue 11, 1988, Pages 1256-1258

  Ophir, Dov ^a   Hahn, Talia ^a   Schattner, Amichai ^b   Wallach, David ^b   Aviel, Aharon ^a  

^a KAPLAN HOSPITAL   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

CHILD; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MAST CELL; MIDDLE EAR EFFUSION; OTITIS MEDIA; PRIORITY JOURNAL;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; MALE; OTITIS MEDIA; TUMOR NECROSIS FACTOR;

EID: 0023698650     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archotol.1988.01860230050021     Document Type: Article

References (27)

1. Carswell EA, Old JL, Kassel LR, et al: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-3670.
2. Beutler B, Cerami A: Cachectin: More than a tumor necrosis factor. N Engl J Med 1987;316: 379-385.
3. Aderka D, Holtmann H, Toker L, et al: Tumor necrosis factor induction by Sendai virus. J Immunol 1986;136:2938-2942.
4. Mannel DN, Falk W, Meltzer MS: Inhibition of nonspecific tumoricidal activity by activated macrophages with anti-serum against a soluble cytotoxic factor. Infect Immun 1981;33:156-164.
5. Mestan J, Digel W, Mittnacht S, et al: Antiviral effects of recombinant tumor necrosis factor in vitro. Nature 1986;323:816-819.
6. Wong GHW, Goeddel DV: Tumor necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 1986;323:819-822.
7. Shalaby RM, Aggarwal BB, Rinderknecht E, et al: Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol 1985;135:2069-2073.
8. Silberstein DS, David JR: Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proc Natl Acad Sci USA 1986;83:1055-1059.
9. Sugarman BJ, Aggarwal BB, Hass PE, et al: Recombinant human tumor necrosis factor-α: Effects on proliferation of normal and transformed cells in vitro. Science 1985;230:943-945.
10. Bernstein JM, Tsutsumi H, Ogra PL: The middle ear mucosal immune system in otitis media with effusion. Am J Otolaryngol 1985; 6:162-168.
11. Ryan AF, Catanzaro A, Wasserman SJ, et al: Secondary immune response in the middle ear: Immunological, morphological and physiological observations. Ann Otol Rhinol Laryngol 1986;95:242-249.
12. Juhn SK, Giebink G, Huff JS, et al: Biochemical and immunochemical characteristics of middle ear effusions in relation to bacteriological findings. Ann Otol Rhinol Laryngol 1980;89(suppl 68):161-167.
13. Palva T, Lehtinen T, Rinne J: Immune complexes in middle ear fluid in chronic secretory otitis media. Ann Otol Rhinol Laryngol 1983; 92:42-44.
14. Meri S, Lehtinen T, Palva T: Complement in chronic secretory otitis media. Arch Otolaryngol Head Neck Surg 1984;110:774-778.
15. Lim DJ, Lewis DM, Schram JL, et al: Otitis media with effusion: Cytological and microbiological correlates. Arch Otolaryngol Head Neck Surg 1979;105:404-412.
16. Yamanaka T, Bernstein JB, Cumella J, et al: Immunologic aspects of otitis media with effusion: Characteristics of lymphocyte and macrophage reactivity. J Infect Dis 1982;145:804-810.
17. Hamaguchi Y, Majima Y, Sakakura K, et al: Lysosomal thiol protease in middle ear effusions. Ann Otol Rhinol Laryngol 1986;95(suppl 124):9-12.
18. Wallach D: Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J Immunol 1984;132:2464-2469.
19. Paparella M, Sipila P, Juhn SK, et al: Subepithelial space in otitis media. Laryngoscope 1985;95:414-420.
20. Steffen M, Abboud M, Potter GK, et al: Human mast cells produce tumor necrosis factor, abstracted. Immunobiol 1987;175:36.
21. Berger G, Hawke M, Ekem K, et al: Mast cells in human middle ear mucosa in health and in disease. J Otolaryngol 1984;13:370-374.
22. Berger G, Hawke M, Ekem K: Bone resorption in chronic otitis media: The role of mast cells. Acta Otolaryngol 1985;100:72-80.
23. DiGiovine F, Manson J, Nuki G, et al: The presence of tumor necrosis factor activity in synovial exudate fluids from patients with osteoarthrosis and rheumatoid arthritis, abstracted. Br J Rheumatol 1986;25(suppl 2):108.
24. Ino Y, Kaneko Y, Takasaka T: Endotoxin in middle ear effusions tested with Limulus assay. Acta Otolaryngol 1985;100:42-50.
25. Bernstein JM: Biological mediators of inflammation in middle ear effusions. Ann Otol Rhinol Laryngol 1976;85(suppl 25):90-96.
26. Boisvert P, Wasserman SI, Schiff M, et al: Histamine-induced middle ear effusion and mucosal histopathology in the guinea pig. Ann Otol Rhinol Laryngol 1985;94:212-215.
27. Berger G, Hawke M, Proops DW, et al: Histamine levels in middle ear effusions. Acta Otolaryngol 1984;98:385-390.